PSA doubling time (PSA DT) appears to be a good predictor of prostate cancer-specific death among men who have completed external-beam radiation therapy, researchers report.
Dr. Anthony V. D’Amico from Brigham and Women’s Hospital, Boston, and colleagues studied the risk of prostate cancer-specific death in 381 men who had undergone external-beam radiation for clinically localized prostate cancer. At diagnosis the median age of the patients was 73 years.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!